Sign in

CIK 0001439222

  • Large accelerated filer

AGIOS PHARMACEUTICALS, INC.

Sign in to watch
Ticker
AGIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-649-8600
Business address
88 SIDNEY STREET, CAMBRIDGE, MA, 02139
Former names
AGIOS PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$371,112
in 2 filings, $371K under 10b5-1 plans

Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Gheuens Sarah −$371K Chief Medical Officer sold 15% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-01-24 Schenkein David P Chief Executive Officer Option exercise +13,533 $0.30 $4K 13,533
2018-01-24 Schenkein David P Chief Executive Officer Sale −13,533 $80.01 $1.1M 0
2018-01-24 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −13,533 141,159
2018-01-23 CELGENE CORP /DE/ 10% owner Purchase +851,154 $67.00 $57.0M 1,374,599
2018-01-23 Hoerter Steven L. Chief Commercial Officer Option exercise · Stock option (right to buy) −25,000 75,000
2018-01-23 Hoerter Steven L. Chief Commercial Officer Option exercise +25,000 $39.76 $994K 25,000
2018-01-23 Hoerter Steven L. Chief Commercial Officer Sale −25,000 $74.83 $1.9M 0
2018-01-23 Hoerter Steven L. Chief Commercial Officer Option exercise · Stock option (right to buy) +25,000 75,000
2018-01-23 Schenkein David P Chief Executive Officer Option exercise +32,875 $0.30 $10K 32,875
2018-01-23 Schenkein David P Chief Executive Officer Sale −32,875 $80.01 $2.6M 0
2018-01-23 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −32,875 5,962
2018-01-23 CELGENE CORP /DE/ 10% owner Purchase +851,154 $67.00 $57.0M 1,374,599
2018-01-16 Schenkein David P Chief Executive Officer Option exercise +53,000 $0.30 $16K 53,000
2018-01-16 Schenkein David P Chief Executive Officer Sale −13,185 $71.77 $946K 39,815
2018-01-16 Schenkein David P Chief Executive Officer Sale −22,304 $73.02 $1.6M 17,511
2018-01-16 Schenkein David P Chief Executive Officer Sale −10,914 $74.11 $809K 6,597
2018-01-16 Schenkein David P Chief Executive Officer Sale −6,597 $74.80 $493K 0
2018-01-16 Schenkein David P Chief Executive Officer Option exercise · Stock option (right to buy) −53,000 154,692
2018-01-12 Alenson Carman Principal Accounting Officer Option exercise +2,150 $52.29 $112K 2,150
2018-01-12 Alenson Carman Principal Accounting Officer Sale −2,150 $75.00 $161K 0

Page 68 of 80 · 1,590 trades